Diabetes and osteoporosis;Diabetes és osteoporosis

Orvosi Hetilap

Volumn 152, Issue 29, 2011, Pages 1161-1166

  Valkusz, Zsuzsanna ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Szegedi Tudom?nyegyetem Altalanos Orvostudomanyi Kar Borgyogyaszati Es Allergologiai Klinika Szeged Koranyi Fasor 6 6720   (Hungary)

Author keywords

antidiabetics; bone; diabetes; fracture; osteoporosis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ADVANCED GLYCATION END PRODUCT; COLLAGEN; CYTOKINE; INSULIN; METFORMIN; SOMATOMEDIN C; VITAMIN D;

ARTICLE; BONE MASS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FALLING; FRAGILITY FRACTURE; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; VITAMIN D DEFICIENCY; WEIGHT GAIN;

EID: 79960015971     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2011.29154     Document Type: Article

References (39)

1. Osteoporosis prevention, diagnosis and therapy. NIH consensus development panel on osteoporosis prevention, diagnosis and therapy. JAMA, 2001, 285, 785-795.
2. Johnell, O., Kanis, J. A: An estimate of the worldwide prevalence and disability associated with, osteoporotic fractures. Osteoporosis Int., 2006, 17, 1726-1733. (Pubitemid 44607392) (Pubitemid 44607392)
3. Wild, S., Roglic, G., Green, A. és mtsai: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27, 1047-1053. (Pubitemid 38579764) (Pubitemid 38579764)
4. Morrison, L. B., Bogan, I. K.: Bone development in diabetic children: A roentgen study. Am. J. Med. Sci., 1927, 174, 313-318.
5. Thrailkill, K. M., Liu, L., Wahl, E. C. és mtsai: Bone formation is impaired in a model of type 1 diabetes. Diabetes, 2005, 54, 2875-2881. (Pubitemid 41401082) (Pubitemid 41401082)
6. Thrailkill, K. M., Lumpkin, C. K. Jr., Bunn, R. C. és mtsai: Is insulin an anabolic agent in bone? Dissecting the diabetic bone for dues. Am. J. Physiol. Endocrinol, Metab., 2005, 289, E735-E745. (Pubitemid 41504371) (Pubitemid 41504371)
7. Jehle, P. M., Jehle, D. R., Mohan, S. és mtsai: Serum levels of insulinlike growth, factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients. J. Endocrinol., 1998, 159, 297-306. (Pubitemid 28520183) (Pubitemid 28520183)
8. Pèrimenis, P., Wémeau, J. L., Vantyghem, M. C.: Hypercalcemia. Ann. Endocrinol. (Paris), 2005, 66, 532-539.
9. Holick, M. P., Chen, T.C.: Vitamin D deficiency: A worldwide problem with health consequences. Am. J. Clin. Nutr., 2008, 87, 1080S-1086S. (Pubitemid 351549267)
10. Pozzilli, P., Manfrini, S., Crinò, A. és mtsai: IMDIAB group. Low levels of 25-hydroxyvitamin D3 and. 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type I diabetes. Horm. Metab. Res., 2005, 37, 680-683. (Pubitemid 41810490) (Pubitemid 41810490)
11. Littorin, B., Blom, P., Schölin, A. és mtsai: Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia, 2006, 49, 2847-2852. (Pubitemid 44730286) (Pubitemid 44730286)
12. Svoren, B. M., Volkening, L. K., Wood, J. R. és mtsai: Significant vitamin D deficiency in youth with type I. diabetes mellitus. J. Pediatr., 2009, 154, 132-134.
13. Gimble, J. M., Zvonic, S., Floyd, Z. E. és mtsai: Playing with bone and fat. J. Cell. Biochem., 2006, 98, 251-266.
14. McCarthy, A. D., Uemura, T., Etcheverry, S. B. és want: Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-1 collagen matrix. Int. J. Biochem. Cell, Biol., 2004, 36, 840-848. (Pubitemid 38299399) (Pubitemid 38299399)
15. Isaia, G. C., D'Amelio, P., Di Bella, S. és mtsai: Is leptin the link between, fat and bone mass? J. Endocrinol. Invest., 2005, 28 (Suppl. 10), 61-65.
16. Cirmanová, V, Bayer, M., Stárka, L. és mtsai: The effect of leptin on bone: An evolving concept of action. Physiol. Res., 2008, 57(Suppl. 1), S143-S151.
17. Alexandraki, K., Piperi, C., Kalofoutis, C. és mtsai: Inflammatory process in type 2 diabetes: The role of cytokines. Ann. N Y Acad. Sci., 2006, 1084, 89-117. (Pubitemid 47091972) (Pubitemid 47091972)
18. De Laet, C., Kanis, J. A., Odén, A. és mtsai: Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos. Int., 2005, 16, 1330-1338. (Pubitemid 41532085) (Pubitemid 41532085)
19. Reid, I. R., Cornish, J., Baldock, P. A.: Nutrition-related peptides and bone homeostasis. J. Bone Miner. Res., 2006, 21, 495-500.
20. Tamaguchi, T, Kanazawa, I., Tamamoto, M. és mtsai: Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone, 2009, 45, 174-179.
21. Crepaldi, G., Romanato, G., Tonin, P. és mtsai: Osteoporosis and body composition. J. Endocrinol. Invest., 2007, 30 (Suppl. 6), 42-47.
22. Dhindsa, S., Bhatia, V., Dhindsa, G. és mtsai: The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients. Diabetes Care, 2007, 30, 1860-1861. (Pubitemid 47036365) (Pubitemid 47036365)
23. Rejnmark, L.: Bone effects of glitazones and other antidiabetic drugs. Curr. Drug Saf., 2008, 3, 194-198.
24. Vestergaard, P.: Bone metabolism in type 2 diabetes and role of thiazolidinediones. Curr. Opin. Endocrinol. Diabetes Obes., 2009, 16, 125-131.
25. Solomon, D. H., Cadarette, S. M., Choudhry, N. K és mtsai: A cohort study of thiazolidinediones and fractures in older adults with diabetes. J. Clin. Endocrinol. Metab., 2009, 94, 2792-2798.
26. Schurman, L., McCarthy, A. D., Sedlinsky, C. és mtsai: Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Exp. Clin. Endocrinol. Diabetes, 2008, 116, 333-340. (Pubitemid 351947863) (Pubitemid 351947863)
27. Monami, M., Cresci, B., Colombini, A. és mtsai: Bone fractures and hypoglycemic treatment in type 2 diabetic patients: A casecontrol study. Diabetes Care, 2008, 31, 199-203. (Pubitemid 351213319) (Pubitemid 351213319)
28. Nuche-Berenguer, B., Moreno, P., Esbrit, P. és mtsai: Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. Calcif. Tissue Int. 2009, 84, 453-461.
29. Kannus, P., Parkkari, J.: Prevention of hip fracture with hip protectors. Age Ageing, 2006, 35 (Suppl. 2), 51 -54.
30. Isidro, M. L., Ruano, B.: Bone disease in diabetes. Curr. Diabetes Rev., 2010, 6, 144-155.
31. Kecgan, T. H. M., Schwartz, A. V, Bauer, D. C. és mtsai: Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women. The Fracture Intervention Trial. Diabetes Care, 2004, 27, 1547-1553. (Pubitemid 38857424) (Pubitemid 38857424)
32. Jude, E. B., Selby, P. L., Lilleystone, P. és mtsai: Biphosphonates in the treatment of Charcot neuropathy: A double-blind randomised controlled trial. Diabetologia, 2001, 44, 2032-2037. (Pubitemid 33124049) (Pubitemid 33124049)
33. Barret-Connor, E., Ensrud, K. E., Harper, K. D. és mtsai: Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effect of 3 years on raloxifene treatment of glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes. Clin. Ther., 2003, 25, 919-930. (Pubitemid 36459698) (Pubitemid 36459698)
34. Bonds, D. E, Larson, J. C., Schwartz, A. V. és mtsai: Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J. Clin. Endocrinol. Metab., 2006, 91, 3404-3410. (Pubitemid 44402111) (Pubitemid 44402111)
35. Janghorbani, M., Feskanich, D., Willett, W. C. és mtsa: Prospective study of diabetes and risk of hip fracture: the Nurses' Health Study. Diabetes Care, 2006, 29, 1573-1578. (Pubitemid 44127583) (Pubitemid 44127583)
36. De Liefde, I. I., van der Klift, M., de Lact, C. E. és mtsai: Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos. Int., 2005, 16, 1713-1720. (Pubitemid 41790880) (Pubitemid 41790880)
37. Ivers, R. Q., Gumming, R. G., Mitchell, P. és mtsai: Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care, 2001, 24, 1198-1203. (Pubitemid 33716398) (Pubitemid 33716398)
38. Strotmeyer, E. S., Cauley, J. A., Schwartz, A. V. és mtsai: Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults. The Health, Aging and Body Composition Study. Arch. Intern. Med., 2005, 165, 1612-1617. (Pubitemid 41124155) (Pubitemid 41124155)
39. Nicodemus, K. K., Folsom, A. R.: Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care, 2001, 24, 1192-1197. (Pubitemid 33716397) (Pubitemid 33716397)